Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Cannon

Showing results (11-20 of 1,137) with videos related to

Pageof 114
Sort By:
Cardiology Clinics|November 10, 2005
Acute coronary syndromes: risk stratification and initial managementChristopher P Cannon
JAMA|November 17, 2005
The IDEAL cholesterol: lower is betterChristopher P Cannon
Reviews in Cardiovascular Medicine|October 17, 2007
Clopidogrel: who, when, and how?Christopher P Cannon
The American Journal of Cardiology|October 3, 2002
Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial)Christopher P Cannon,
Current Cardiology Reports|September 12, 2000
Low molecular weight heparin in acute coronary syndromesC P Cannon
Circulation|August 8, 2001
Importance of TIMI 3 flowC P Cannon
Atherosclerosis. Supplements|February 26, 2004
The next step in cardiovascular protectionChristopher P Cannon
Reviews in Cardiovascular Medicine|November 10, 2009
Introduction: Update on the evaluation and treatment of chronic anginaChristopher P Cannon
European Heart Journal|September 10, 2019
Don't stop the statin!Christopher P Cannon
Journal of the American College of Cardiology|November 7, 1999
Overcoming thrombolytic resistance: rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarctionC P Cannon
Pageof 114

Showing results (11-20 of 1,137) with videos related to

Sort By:
Pageof 114
Cardiology Clinics|November 10, 2005
Acute coronary syndromes: risk stratification and initial managementChristopher P Cannon
JAMA|November 17, 2005
The IDEAL cholesterol: lower is betterChristopher P Cannon
Reviews in Cardiovascular Medicine|October 17, 2007
Clopidogrel: who, when, and how?Christopher P Cannon
The American Journal of Cardiology|October 3, 2002
Effectiveness of clopidogrel versus aspirin in preventing acute myocardial infarction in patients with symptomatic atherothrombosis (CAPRIE trial)Christopher P Cannon,
Current Cardiology Reports|September 12, 2000
Low molecular weight heparin in acute coronary syndromesC P Cannon
Circulation|August 8, 2001
Importance of TIMI 3 flowC P Cannon
Atherosclerosis. Supplements|February 26, 2004
The next step in cardiovascular protectionChristopher P Cannon
Reviews in Cardiovascular Medicine|November 10, 2009
Introduction: Update on the evaluation and treatment of chronic anginaChristopher P Cannon
European Heart Journal|September 10, 2019
Don't stop the statin!Christopher P Cannon
Journal of the American College of Cardiology|November 7, 1999
Overcoming thrombolytic resistance: rationale and initial clinical experience combining thrombolytic therapy and glycoprotein IIb/IIIa receptor inhibition for acute myocardial infarctionC P Cannon
Pageof 114